Goldenwell Biotech Operating Income Growth & History (GWLL)

Goldenwell Biotech's operating income was −$113,326 for fiscal 2025.

View full Goldenwell Biotech company overview

Goldenwell Biotech annual operating income history

Goldenwell Biotech annual operating income

Fiscal yearPeriod endedOperating incomeChangeGrowth
20252025-12-31−$113,326$9,772
20242024-12-31−$123,098−$7,272
20232023-12-31−$115,826$869,279
20222022-12-31−$985,105−$866,838
20212021-12-31−$118,267

Goldenwell Biotech operating income trends

Between the periods ended 2021-12-31 and 2025-12-31, Goldenwell Biotech's operating income increased from −$118,267 to −$113,326, a change of $4,941. The latest reported quarter, Q2 2026, shows −$34,776.

About the metric

What operating income means

Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.

Calculation and source

SEC-reported operating income

TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Goldenwell Biotech source filings ↗

Community posts

It’s quiet here.

No posts about GWLL yet. Start the conversation.

Write the first post